Chitosan-modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2013 Mar 7

PMID 23463262

Citations 82

Authors

Yichao Wang

Puwang Li

Lingxue Kong

Affiliations

Soon will be listed here.

Abstract

Shortage of functional groups on surface of poly(lactide-co-glycolide) (PLGA)-based drug delivery carriers always hampers its wide applications such as passive targeting and conjugation with targeting molecules. In this research, PLGA nanoparticles were modified with chitosan through physical adsorption and chemical binding methods. The surface charges were regulated by altering pH value in chitosan solutions. After the introduction of chitosan, zeta potential of the PLGA nanoparticle surface changed from negative charge to positive one, making the drug carriers more affinity to cancer cells. Functional groups were compared between PLGA nanoparticles and chitosan-modified PLGA nanoparticles. Amine groups were exhibited on PLGA nanoparticle surface after the chitosan modification as confirmed by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. The modified nanoparticles showed an initial burst release followed by a moderate and sustained release profile. Higher percentage of drugs from cumulative release can be achieved in the same prolonged time range. Therefore, PLGA nanoparticles modified by chitosan showed versatility of surface and a possible improvement in the efficacy of current PLGA-based drug delivery system.

Citing Articles

Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment.

Kenechukwu F, Ugwu K, Offorbuike C, Ojukwu E, Gugu T, Eze R BMC Chem. 2025; 19(1):64.

PMID: 40057800 PMC: 11890727. DOI: 10.1186/s13065-025-01422-4.

Development of an Innovative Dual Construct for Targeted Drug Delivery in the Oral Cavity.

Mazzinelli E, Favuzzi I, Messina M, Fratocchi G, Vincenzoni F, Santo Stefano E Pharmaceutics. 2025; 17(2).

PMID: 40006639 PMC: 11859521. DOI: 10.3390/pharmaceutics17020272.

Efficient and Rapid Microfluidics Production of Bio-Inspired Nanoparticles Derived from Silkworm for Enhanced Breast Cancer Treatment.

Mansor M, Gao Z, Howard F, MacInnes J, Zhao X, Muthana M Pharmaceutics. 2025; 17(1).

PMID: 39861742 PMC: 11768208. DOI: 10.3390/pharmaceutics17010095.

Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.

Patel S, Salaman S, Kapoor D, Yadav R, Sharma S Z Naturforsch C J Biosci. 2024; .

PMID: 39566511 DOI: 10.1515/znc-2024-0208.

Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery.

Marecki E, Oh K, Knight P, Davidson B Biomicrofluidics. 2024; 18(5):051503.

PMID: 39296325 PMC: 11410388. DOI: 10.1063/5.0201465.

References

Yang J, Wan Y, Yang J, Bei J, Wang S . Plasma-treated, collagen-anchored polylactone: Its cell affinity evaluation under shear or shear-free conditions. J Biomed Mater Res A. 2003; 67(4):1139-47. DOI: 10.1002/jbm.a.10034. View

Hood E, Simone E, Wattamwar P, Dziubla T, Muzykantov V . Nanocarriers for vascular delivery of antioxidants. Nanomedicine (Lond). 2011; 6(7):1257-72. PMC: 3342819. DOI: 10.2217/nnm.11.92. View

Ku Y, Shim I, Lee J, Park Y, Rhee S, Nam S . Chitosan/poly(L-lactic acid) multilayered membrane for guided tissue regeneration. J Biomed Mater Res A. 2008; 90(3):766-72. DOI: 10.1002/jbm.a.31846. View

Parveen S, Sahoo S . Polymeric nanoparticles for cancer therapy. J Drug Target. 2008; 16(2):108-23. DOI: 10.1080/10611860701794353. View

Li P, Wang Y, Zeng F, Chen L, Peng Z, Kong L . Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res. 2011; 346(6):801-6. DOI: 10.1016/j.carres.2011.01.027. View

Quemeneur F, Rinaudo M, Pepin-Donat B . Influence of molecular weight and pH on adsorption of chitosan at the surface of large and giant vesicles. Biomacromolecules. 2007; 9(1):396-402. DOI: 10.1021/bm700943j. View

Gaumet M, Vargas A, Gurny R, Delie F . Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2007; 69(1):1-9. DOI: 10.1016/j.ejpb.2007.08.001. View

Guo C, Gemeinhart R . Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. Eur J Pharm Biopharm. 2008; 70(2):597-604. PMC: 2612535. DOI: 10.1016/j.ejpb.2008.06.008. View

Jeon O, Lim H, Lee M, Song S, Kim B . Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA. J Drug Target. 2007; 15(3):190-8. DOI: 10.1080/10611860601143479. View

10.

Chandy T, Wilson R, Rao G, Das G . Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(epsilon-caprolactone) microspheres. J Biomater Appl. 2002; 16(4):275-91. DOI: 10.1106/088532802024246. View

11.

Morlock M, Kissel T, Li Y, Koll H, Winter G . Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J Control Release. 1998; 56(1-3):105-15. DOI: 10.1016/s0168-3659(98)00070-4. View

12.

Kato Y, Onishi H, Machida Y . Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol. 2003; 4(5):303-9. DOI: 10.2174/1389201033489748. View

13.

Zhao H, Yung L . Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm. 2007; 349(1-2):256-68. DOI: 10.1016/j.ijpharm.2007.07.040. View

14.

Shen H, Hu X, Bei J, Wang S . The immobilization of basic fibroblast growth factor on plasma-treated poly(lactide-co-glycolide). Biomaterials. 2008; 29(15):2388-99. DOI: 10.1016/j.biomaterials.2008.02.008. View

15.

Shen H, Hu X, Yang F, Bei J, Wang S . Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide). Biomaterials. 2007; 28(29):4219-30. DOI: 10.1016/j.biomaterials.2007.06.004. View

16.

Mu L, Feng S . Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release. 2002; 80(1-3):129-44. DOI: 10.1016/s0168-3659(02)00025-1. View

17.

Wang Z, Wang Z, Sun C, Wang C, Jiang T, Wang S . Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2009; 31(5):908-15. DOI: 10.1016/j.biomaterials.2009.09.104. View

18.

Esmaeili F, Ghahremani M, Ostad S, Atyabi F, Seyedabadi M, Malekshahi M . Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J Drug Target. 2008; 16(5):415-23. DOI: 10.1080/10611860802088630. View

19.

Contado C, Vighi E, Dalpiaz A, Leo E . Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. Anal Bioanal Chem. 2012; 405(2-3):703-11. DOI: 10.1007/s00216-012-6113-5. View

20.

Simonoska Crcarevska M, Glavas Dodov M, Goracinova K . Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm. 2007; 68(3):565-78. DOI: 10.1016/j.ejpb.2007.06.007. View